Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 17.65% institutional investors, 22.79% insiders, and 59.55% retail investors. Fmr is the largest institutional shareholder, holding 11.19% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.13% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Roivant Sciences | 17.65% | 22.79% | 59.55% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 77.98M | 11.19% | $2.16B |
| Morgan stanley | 51.83M | 7.44% | $1.44B |
| Blackrock funding, inc. /de | 44.25M | 6.35% | $1.23B |
| Vanguard group | 42.06M | 6.18% | $912.68M |
| Sb investment advisers (uk) | 40.32M | 5.93% | $609.97M |
| Blackrock | 35.37M | 4.41% | $373.86M |
| Qvt financial lp | 25.16M | 3.61% | $696.97M |
| Ubs group | 22.62M | 3.25% | $626.56M |
| State street | 16.19M | 2.32% | $448.37M |
| Adage capital partners gp | 12.79M | 1.84% | $354.40M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Qvt financial lp | 25.16M | 51.04% | $696.97M |
| Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
| Patient square capital lp | 8.17M | 40.13% | $226.20M |
| Whitefort capital management, lp | 1.42M | 11.59% | $39.31M |
| Davern capital partners, lp | 873.40K | 6.64% | $24.19M |
| Cutter capital management, lp | 1.30M | 5.71% | $13.12M |
| Blackbarn capital partners lp | 2.29M | 5.09% | $63.30M |
| Penn davis mcfarland | 1.58M | 4.98% | $55.92M |
| Darwin global management | 6.80M | 4.76% | $179.52M |
| Adar1 capital management | 3.35M | 4.76% | $50.65M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 77.98M | 0.11% | 12.20M |
| Farallon capital management | 9.68M | 1.53% | 9.64M |
| Darwin global management | 6.80M | 4.76% | 6.80M |
| Norges bank | 5.20M | 0.01% | 5.20M |
| Aqr capital management | 5.95M | 0.07% | 5.07M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sb investment advisers (uk) | 40.32M | 4.60% | -19.64M |
| Morgan stanley | 51.83M | 0.09% | -6.53M |
| Anchorage capital group | - | - | -4.83M |
| Avoro capital advisors | - | - | -4.65M |
| Toms capital investment management lp | - | - | -4.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Darwin global management | 6.80M | 4.76% | 6.80M | $179.52M |
| Norges bank | 5.20M | 0.01% | 5.20M | $112.75M |
| Vanguard fiduciary trust | 2.81M | 0.02% | 2.81M | $77.87M |
| Maverick capital | 1.63M | 0.52% | 1.63M | $45.07M |
| Cutter capital management, lp | 1.30M | 5.71% | 1.30M | $13.12M |
Sold Out
| Holder | Change |
|---|---|
| Optiver b.v. | -2.00 |
| Stephens consulting | -3.00 |
| Mather group, llc. | -13.00 |
| Cornerstone planning group | -27.00 |
| Fny investment advisers | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 240 | -42.72% | 123,029,474 | -75.82% | 17 | 0.33% | 131 | -49.42% | 64 | -33.33% |
| Dec 31, 2025 | 302 | -16.80% | 336,769,510 | -32.86% | 49 | 0.91% | 194 | 1.04% | 60 | -37.50% |
| Sep 30, 2025 | 297 | -14.41% | 349,519,827 | -24.94% | 51 | 1.19% | 157 | -11.80% | 81 | -23.58% |
| Jun 30, 2025 | 351 | 8.67% | 514,292,667 | -7.04% | 72 | 1.24% | 180 | 19.21% | 107 | 0.94% |
| Mar 31, 2025 | 15 | -95.41% | 102,194,746 | -81.83% | 14 | 0.23% | 6 | -96.18% | 3 | -97.12% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 29.70M | 4.13% | 268.72K |
| Fidelity Growth Company Fund | 22.52M | 3.13% | 184.80K |
| Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
| Vanguard Total Stock Mkt Idx Inv | 15.99M | 2.22% | 1.18M |
| iShares Core S&P Mid-Cap ETF | 15.35M | 2.13% | -83.21K |
| Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
| Vanguard Small Cap Index | 11.55M | 1.61% | 842.11K |
| SPDR® S&P Biotech ETF | 7.21M | 1.06% | 16.07K |
| Vanguard Small Cap Growth Index Inv | 6.67M | 0.93% | 639.50K |
| Invesco S&P MidCap Quality ETF | 6.02M | 0.89% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 27, 2026 | Venker Eric | President & Immunovant CEO | Sell | $6.99M |
| Jun 30, 2026 | Fitzgerald Meghan | - | Sell | $349.00K |
| Jun 29, 2026 | Epperly Melissa B, | - | Sell | $514.87K |
| Jun 29, 2026 | Epperly Melissa B, | - | Sell | $95.38K |
| Jun 26, 2026 | MANCHESTER KEITH S | - | Sell | $11.07M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | - | 27 |
| 2026 Q1 | - | 24 |
| 2025 Q4 | - | 53 |
| 2025 Q3 | 1 | 9 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools